{"type":"trials","record":{"id":35410,"source_id":"clinicaltrials-gov","external_id":"NCT06056934","title":"Pain Management in Elderly Patients With or Without Cognitive Frailty Hospitalized \"ALGOGER\"","brief_summary":"Today, the standard treatment is to operate on patients suffering from a fracture of the upper end of the femur. The aim of treatment is to enable immediate mobilization and weight-bearing, and as rapid a return as possible to normal living conditions. Surgery is the best treatment option. It maximizes the chances of functional recovery and, by stabilizing the fracture, reduces pain: it is the most effective and longest-lasting analgesic. Adequate analgesia in elderly patients with femoral neck fractures has a beneficial effect. In particular, a lower probability of death has been shown in cervical fracture patients receiving opioids than those not receiving them. Pain management is a matter of protocol in the UPOG department of the CHU de Nîmes. Pain prevention appears to improve morbidity and mortality. Cognitive fragility, such as neurocognitive disorders, confusion or long-term use of psychotropic drugs, appear to be confounding factors in pain management. The investigators therefore wished to observe whether the presence of cognitive fragility has an impact on pain management on the ward, despite protocol-based management.","overall_status":"Completed","phases":[],"study_type":"OBSERVATIONAL","sponsor":"Centre Hospitalier Universitaire de Nīmes","enrollment":350,"countries":["France"],"start_date":"2023-03-09","completion_date":"2023-10-30","last_update_date":"2025-03-10","source_url":"https://clinicaltrials.gov/study/NCT06056934","editorial_summary":"A registered study indexed because it matched monitored longevity research terms. Registry status: Completed. Registration does not establish safety or effectiveness.","first_seen_at":"2026-09-25T01:20:20.087268+00:00","last_seen_at":"2026-09-25T06:10:07.378+00:00","metadata":{"sex":"ALL","acronym":"ALGOGER","age_range":"76 Years","comparator":null,"organization":"Centre Hospitalier Universitaire de Nīmes","interventions":[],"registry_source":"ClinicalTrials.gov","outcome_measures":["Morphine sulfate equivalent rate in each group, mg/day — Pre-operative","Morphine sulfate equivalent rate in each group, mg/day — Early post-operative between Day 0 and Day 3","Morphine sulfate equivalent rate in each group, mg/day — Late post-operative between Day 4 and day 7"],"design_description":null,"source_has_results":false},"controlled_terms":["Cognitive Deterioration"],"relevance_confidence":80,"source_quality_score":100,"freshness_score":65,"publication_state":"published","match_explanation":"Title contains controlled term: frailty.","quality_checked_at":"2026-09-25T06:10:20.034853+00:00","duplicate_cluster_key":"id:nct06056934","duplicate_of_id":null,"evidence_snapshot":{"status":"structured","version":1,"duration":"2023-03-09 to 2023-10-30","comparator":null,"confidence":"structured-source","population":"ALL · 76 Years","provenance":{"duration":"start_date and completion_date","comparator":"registry arm fields","population":"registry eligibility fields","intervention":"registry intervention fields","participants":"enrollment","study_design":"study_type and registry design fields","evidence_stage":"phases","reported_outcome":"not available","outcomes_measured":"registry outcome-measure fields"},"generated_at":"2026-09-25T06:10:07.521Z","intervention":[],"participants":350,"study_design":"OBSERVATIONAL","subject_scope":"Human clinical study registration","evidence_stage":"Phase not reported","safety_context":"Eligibility, adverse-event details, and clinical decisions must be checked in the official registry and with qualified clinicians.","source_support":"Structured registry protocol metadata; no finding-level conclusion is generated.","main_limitation":"This is a study registration. No reusable structured result is available here, so it cannot show whether the intervention worked or was safe.","reported_outcome":null,"outcomes_measured":["Morphine sulfate equivalent rate in each group, mg/day — Pre-operative","Morphine sulfate equivalent rate in each group, mg/day — Early post-operative between Day 0 and Day 3","Morphine sulfate equivalent rate in each group, mg/day — Late post-operative between Day 4 and day 7"],"regulatory_context":"Trial registration is not regulatory approval and does not establish that an intervention is available."},"clinical_trial_topics":[{"topic_slug":"frailty","is_published":true,"match_reasons":["Title contains controlled term: frailty.","Title supplies longevity context: frailty, frail.","Study type is explicitly identified as OBSERVATIONAL."],"matched_fields":["title","title context","study type"],"relevance_score":80,"intelligence_topics":{"name":"Frailty","slug":"frailty"}}],"content_sources":{"name":"ClinicalTrials.gov","homepage_url":"https://clinicaltrials.gov/"}},"canonical_url":"https://www.immortal.life/trials/35410","automation_disclosure":"Generated automatically from cited source metadata. No scientist, clinician, researcher, editor, or human reviewer evaluates this publication before release."}